Rethinking and redefining the definitions and how we measure availability and affordability of medicines and technologies for non-communicable diseases.
作者信息
Mettraux Céline, Gilmoor Andrew, Ewen Margaret, Besançon Stéphane, Giachino Marina, Laurson-Doube Joanna, Lepeska Molly, Macé Cécile, Perrin Christophe, Tenorio Mucha Janeth, Turkie Rosalind, Beran David
机构信息
Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Health Action International, Amsterdam, Netherlands.
出版信息
BMJ Glob Health. 2025 Aug 4;10(8):e019355. doi: 10.1136/bmjgh-2025-019355.
Abstract
摘要
相似文献
1
Rethinking and redefining the definitions and how we measure availability and affordability of medicines and technologies for non-communicable diseases.重新思考并重新定义非传染性疾病药品和技术的可及性及可负担性的定义以及我们衡量它们的方式。
BMJ Glob Health. 2025 Aug 4;10(8):e019355. doi: 10.1136/bmjgh-2025-019355.
2
Prices, availability, and affordability of adult medicines in 54 low-income and middle-income countries: evidence based on a secondary analysis.54个低收入和中等收入国家成人药品的价格、可及性和可负担性：基于二次分析的证据
Lancet Glob Health. 2025 Jan;13(1):e50-e58. doi: 10.1016/S2214-109X(24)00442-X.
3
Availability and affordability of essential medicines and diagnostic tests for diabetes mellitus in Africa.非洲糖尿病基本药物和诊断检测的可及性和可负担性。
Trop Med Int Health. 2022 Nov;27(11):942-960. doi: 10.1111/tmi.13819. Epub 2022 Oct 18.
4
A survey of availability, price, and affordability of innovative negotiated anticancer medicines: a retrospective study in Jiangsu Province, eastern China.创新型谈判抗癌药物的可及性、价格及可负担性调查：中国东部江苏省的一项回顾性研究
BMC Public Health. 2025 Jul 3;25(1):2313. doi: 10.1186/s12889-025-23570-x.
5
Primary healthcare system readiness for the prevention and management of non-communicable diseases in Nepal: a mixed-methods study.尼泊尔初级卫生保健系统对非传染性疾病的预防和管理的准备情况：一项混合方法研究。
Res Sq. 2025 Jun 12:rs.3.rs-6755631. doi: 10.21203/rs.3.rs-6755631/v1.
6
Barriers and Facilitators to Patient Utilization of Non-Communicable Disease Services in Primary Healthcare Facilities in Nepal: A Qualitative Study.尼泊尔初级卫生保健机构中患者使用非传染性疾病服务的障碍与促进因素：一项定性研究
Res Sq. 2024 Nov 15:rs.3.rs-5324989. doi: 10.21203/rs.3.rs-5324989/v1.
7
Pakistan's first medicine price deregulation policy: assessing its impact on prices, affordability, and availability of oral anti-diabetic medicines in private pharmacies.巴基斯坦首个药品价格放开政策：评估其对私立药店口服抗糖尿病药物价格、可负担性及可获得性的影响。
Front Pharmacol. 2025 Jul 16;16:1627735. doi: 10.3389/fphar.2025.1627735. eCollection 2025.
8
Economic assessment of potential changes to essential medicines for diabetes in Uganda.乌干达糖尿病基本药物潜在变化的经济评估。
PLoS One. 2025 Jun 25;20(6):e0326806. doi: 10.1371/journal.pone.0326806. eCollection 2025.
9
How do we define the policy impact of public health research? A systematic review.我们如何定义公共卫生研究的政策影响？一项系统综述。
Health Res Policy Syst. 2017 Oct 2;15(1):84. doi: 10.1186/s12961-017-0247-z.
10
Understanding patient pathways to Mother and Baby Units: a longitudinal retrospective service evaluation in the UK.了解患者通往母婴病房的路径：英国一项纵向回顾性服务评估
Health Soc Care Deliv Res. 2025 Jul 16:1-17. doi: 10.3310/GDVS2427.
本文引用的文献
1
Using government data to understand the use and availability of medicines for hypertension and diabetes: lessons from Peru.利用政府数据了解高血压和糖尿病药物的使用情况及可及性：来自秘鲁的经验教训
J Pharm Policy Pract. 2022 Nov 18;15(1):86. doi: 10.1186/s40545-022-00481-5.
2
A global perspective on the issue of access to insulin.从全球视角看胰岛素获取问题。
Diabetologia. 2021 May;64(5):954-962. doi: 10.1007/s00125-020-05375-2. Epub 2021 Jan 23.
3
Housing as a determinant of health equity: A conceptual model.住房作为健康公平的决定因素：概念模型。
Soc Sci Med. 2019 Dec;243:112571. doi: 10.1016/j.socscimed.2019.112571. Epub 2019 Sep 25.
4
Insulin prices, availability and affordability in 13 low-income and middle-income countries.13个低收入和中等收入国家的胰岛素价格、可及性和可负担性
BMJ Glob Health. 2019 Jun 11;4(3):e001410. doi: 10.1136/bmjgh-2019-001410. eCollection 2019.
5
Beyond availability and affordability: how access to medicines affects non-communicable disease outcomes.超越可及性与可负担性：药品可及性如何影响非传染性疾病的治疗结果
Lancet Public Health. 2017 Sep;2(9):e390-e391. doi: 10.1016/S2468-2667(17)30168-8. Epub 2017 Sep 5.
6
Access to Medications for Cardiovascular Diseases in Low- and Middle-Income Countries.低收入和中等收入国家心血管疾病药物的可及性
Circulation. 2016 May 24;133(21):2076-85. doi: 10.1161/CIRCULATIONAHA.115.008722.
7
Medicines availability for non-communicable diseases: the case for standardized monitoring.非传染性疾病的药品供应：标准化监测的情况
Global Health. 2015 May 7;11:18. doi: 10.1186/s12992-015-0105-0.
8
Practical measurement of affordability: an application to medicines.实际支付能力的衡量：以药品为例。
Bull World Health Organ. 2012 Mar 1;90(3):219-27. doi: 10.2471/BLT.10.084087. Epub 2012 Jan 27.
9
Health systems financing and the path to universal coverage.卫生系统筹资与全民覆盖之路。
Bull World Health Organ. 2010 Jun;88(6):402. doi: 10.2471/BLT.10.078741.
10
A global action plan for the prevention and control of pneumonia.肺炎预防与控制全球行动计划
Bull World Health Organ. 2008 May;86(5):322-2A. doi: 10.2471/blt.08.053348.
Zotero 插件